Cargando…
Predictive Biomarkers for a Personalized Approach in Resectable Pancreatic Cancer
The mainstay treatment for patients with immediate resectable pancreatic cancer remains upfront surgery, which represents the only potentially curative strategy. Nevertheless, the majority of patients surgically resected for pancreatic cancer experiences disease relapse, even when a combination adju...
Autores principales: | Merz, Valeria, Mangiameli, Domenico, Zecchetto, Camilla, Quinzii, Alberto, Pietrobono, Silvia, Messina, Carlo, Casalino, Simona, Gaule, Marina, Pesoni, Camilla, Vitale, Pasquale, Trentin, Chiara, Frisinghelli, Michela, Caffo, Orazio, Melisi, Davide |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114435/ https://www.ncbi.nlm.nih.gov/pubmed/35599791 http://dx.doi.org/10.3389/fsurg.2022.866173 |
Ejemplares similares
-
Targeting FGFR Pathway Is Not an Effective Therapeutic Strategy in Patients with Unselected Metastatic Esophagogastric Cancer Resistant to Trastuzumab
por: Zecchetto, Camilla, et al.
Publicado: (2023) -
Exceptional Clinical Response to Alectinib in Pancreatic Acinar Cell Carcinoma With a Novel ALK-KANK4 Gene Fusion
por: Gaule, Marina, et al.
Publicado: (2022) -
Targeting KRAS: The Elephant in the Room of Epithelial Cancers
por: Merz, Valeria, et al.
Publicado: (2021) -
Multicenter Retrospective Analysis of Second-Line Therapy after Gemcitabine Plus Nab-Paclitaxel in Advanced Pancreatic Cancer Patients
por: Merz, Valeria, et al.
Publicado: (2020) -
YAP Activation Is Associated with a Worse Prognosis of Poorly Cohesive Gastric Cancer
por: Bencivenga, Maria, et al.
Publicado: (2023)